共 5 条
[2]
ACCESS TO RECOMBINANT ERYTHROPOIETIN BY MEDICARE-ENTITLED DIALYSIS PATIENTS IN THE 1ST YEAR AFTER FDA APPROVAL
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1992, 268 (11)
:1434-1440
[5]
RECOMBINANT ERYTHROPOIETIN AND MEDICARE PAYMENT
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1991, 266 (02)
:247-252